Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase III trial of beclometasone (SGX203) in paediatric patients with Crohn's disease

Trial Profile

Phase III trial of beclometasone (SGX203) in paediatric patients with Crohn's disease

Status: Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 29 Jul 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Beclometasone (Primary)
  • Indications Crohn's disease
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 29 Jul 2019 According to a Soligenix media release, the conduct of this trial is pending partnership and/or additional funding.
    • 26 Jan 2016 According to a Soligenix media release, this trial is expected to be initiated during the first half of 2016.
    • 14 Apr 2015 Primary results are expected to be available in the first half of 2017, according to a Soligenix media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top